comparemela.com

Latest Breaking News On - Mary jane elliott matthew neal - Page 1 : comparemela.com

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Preliminary Results

Investegate announcements from Oxford Biomedica PLC, Preliminary Results

United statesUnited kingdomMatthew treagusRoch doliveuxOxford biomedica lentivectorNamratap patelOxford biomedicaSophia bolhassanBristol myers squibbIsolere bioMichael haydenDame kay daviesMary jane elliott matthew nealTim kellyStuart paynterAndrew heath

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Board Appointment

Investegate announcements from Oxford Biomedica PLC, Board Appointment

United kingdomMid glamorganUnited kingdom generalRoch doliveuxMary jane elliott matthew nealStuart paynterNamratap patelOxford biomedicaSophia bolhassanNamrata patelPublic administration marketingBoehringer ingelheimUniversity of south walesBristol myers squibbProcter gambleCranfield school of management

Oxford BioMedica plc: Oxford Biomedica broadens its viral vector capabilities with the launch of Oxford Biomedica Solutions, a full scope AAV business in Boston, following closing of its deal with Homology

Unique platform offering capabilities from vector design and process development through to clinical trials is now available to new customers Oxford, UK - 11 March 2022: Oxford Biomedica plc (LSE:OXB)

United kingdomTim kellyMary jane elliott matthew nealStuart paynterOxford biomedicaSophia bolhassanHomology medicines incConsilium strategic communicationsOxford biomedica solutionsHomology medicinesAdeno associated virusDrug substanceDrug productUnited kingdom basedChief financialStrategic communications

Investegate |Oxford Biomedica PLC Announcements | Oxford Biomedica PLC: Director Declaration

Investegate announcements from Oxford Biomedica PLC, Director Declaration

United kingdomMary jane elliott matthew nealStuart paynterOxford biomedicaSophia bolhassanBoehringer ingelheimBristol myers squibbConsilium strategic communicationsJohn dawsonExecutive directorNon executive directorChief financialStrategic communicationsJane elliottMatthew nealHomology medicine

Investegate |Oxford BioMedica plc Announcements | Oxford BioMedica plc: Oxford Biomedica announces update to agreement with Sio Gene Therapies

Investegate announcements from Oxford BioMedica plc, Oxford Biomedica announces update to agreement with Sio Gene Therapies

United kingdomRoch doliveuxMary jane elliott matthew nealStuart paynterOxford biomedicaSophia bolhassanBoehringer ingelheimBristol myers squibbConsilium strategic communicationsSio gene therapiesSiogene therapiesAxovant gene therapiesGene therapyChief financialJane elliottHomology medicine

vimarsana © 2020. All Rights Reserved.